71 Infos zu Alex Zhavoronkov

7 Aktuelle Nachrichten

Alex Zhavoronkov. CEO Insilico Medicine. WEDNESDAY, SEPTEMBER 30. Wednesday, September 30th, :00 AM Spotlight Talk: Using AI to Accelerate ...

Insilico Medicine is among several startups trying to harness artificial intelligence to speed up development of drugs.

3 Sept Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs

Qiming-backed Insilico Medicine uses AI and deep learning to speed up drug discovery.

3  Bilder zu Alex Zhavoronkov

7 Profile in Sozialen Netzwerken

View Alex Zhavoronkov's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Alex Zhavoronkov ...

Interested in biogerontology and regenerative medicine. Follow me on Facebook /biogerontology

Curated profile of Alex Zhavoronkov, Co-founder, InSilico Medicine including career history, news and intelligence, portfolio companies and investments.

2 Hobbys & Interessen

Insilico Medicine has developed GENTRL, a new artificial intelligence system for drug discovery that dramatically accelerates the process from years t

Alex Zhavoronkov, PhD's stories. Expert in AI for healthcare and longevity biotechnology

4 Bücher zum Namen

Alex Zhavoronkov is the author of The Ageless Generation (3.91 avg rating, 44 ratings, 14 reviews, published 2013)

In the latest Technical View, the Biogerontology Research Foundation's Alex Zhavoronkov lays out the latest factors affecting longevity and how schemes and ...

Papers by Alex Zhavoronkov with links to code and results.

1 Songs & Musik

Listen to this episode from Interviews: Business and Tech on Spotify. Artificial intelligence offers the promise of better health, faster drug discovery and...

3 Dokumente

View all of Alex Zhavoronkov's Presentations.

· Submission history. From: Alex Zhavoronkov [view email] [v1] Fri, 22 Jan ​:49:26 UTC (863 KB). Full-text links: ...

... Kurbanov, Aleksey Artamonov, Vladimir Aladinskiy, Mark Veselov, Artur Kadurin, Sergey Nikolenko, Alan Aspuru-Guzik, Alex Zhavoronkov.

2 Wissenschaftliche Publikationen

Alex Zhavoronkov, Polina Mamoshina, Quentin Vanhaelen and Alex Aliper are affiliated with Insilico Medicine, Inc., a company engaged in aging research, ...

List of computer science publications by Alex Zhavoronkov

1 Allgemeine Veröffentlichungen

Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine and aging economics. He is founder of Insilico Medicine, the director of the ...

1 Video- & Audioinhalte

In this interview, Brent Nally talks with Alex Zhavoronkov about Insilico Medicine's approach to drug discovery, the relationship between COVID-19 and age-re...

10 Meinungen & Artikel

Stream the LongeCity interviews episode, Alex Zhavoronkov - In Silico Medicine, free & on demand on iHeartRadio.

· Alex Zhavoronkov founded Insilico Medicine, an early company in the young longevity industry, and the first of many to focus on machine ...

· Alex Zhavoronkov, CEO of Insilico Medicine, lifts the lid on the role of AI in target discovery, identification, and validation. He also offers his ...

Artificial intelligence offers the promise of better health, faster drug discovery and testing, to c

30 Webfunde aus dem Netz

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation.

Dr. Alex Zhavoronkov is the founder and CEO of InSilico Medicine, a global leader in the next-generation artificial intelligence technologies for drug discovery, ...

Alex Zhavoronkov · MIT Technology Review Selects AI Molecular Design as a Breakthrough of the Year and Highlights… · Alliance for Artificial Intelligence in ...

Alex Zhavoronkov is the author of over 90 research publications in the peer-​reviewed journals and books including “The Ageless Generation: How advances in ...

Alex Zhavoronkov of In Silico Medicine has written a fair amount on the economics of aging and the urgent need for greater research and ...

Alex Zhavoronkov. Founder, Insilico Medicine. Dr. Zhavoronkov is a biogerontologist and artificial intelligence scientist with deep passion for longevity science ...

Alex Zhavoronkov is CEO of Insilico Medicine. Insilico Medicine is a leader in next-​generation artificial intelligence (AI) technologies for drug discovery and ...

Our friend Alex Zhavoronkov, Founder and CEO of Insilico Medicine, a company we feature in Juvenescence, recently made the following presentation at ...

Alex Zhavoronkov, Ph.D., the author of The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy, is the director and a trustee ...

Today Insilico Medicine announced the appointment of its founder and CEO, Dr. Alex Zhavoronkov, to the faculty of the Buck Institute for ...

Learn more about Health Horizons Conference our speaker Alex Zhavoronkov

(Alex Zhavoronkov, Insilico Medicine) by Faces of Digital Health instantly on your tablet, phone or browser - no downloads needed.

An interview with Alex Zhavoronkov, CEO of Insilico Medicine, a leading BioTech and Artificial Intelligence company focusing on Drug & Bio Marker Discovery.

· Alex Zhavoronkov here to share his insights on the current state of longevity medicine and the next wave of aging research strategies. Dr.

Read the latest news about Alex Zhavoronkov on TechCrunch

· Today's episode on Redefining Medicine features Alex Zhavoronkov, PhD. As CEO of Insilico ...Dauer: 27:12Gepostet:

Read writing from Alex Zhavoronkov, PhD in Noteworthy - The Journal Blog. Founder of Insilico Medicine, adj. prof at the Buck. I speak at 40+ events per year...

Alex Zhavoronkov has been researching the use of AI in aging for years. He is the CEO of Insilico Medicine, a Baltimore-based leader in the ...

AI for Health. Alex Zhavoronkov. HomeREPLAY 2020Quickfire Challenge​SpeakersUse casesNewsAbout usPast eventsREGISTERLogin. AZ ...

Alex Zhavoronkov. Dr. Zhavoronkov is the CEO of Insilico Medicine, a Baltimore-​based leader in the next-generation artificial intelligence and blockchain ...